Home / Resources (page 52)

Resources

RESOURCES

CGM Candidates

In your opinion, which diabetes patients are the best candidates for CGM?

- Patients on more than five diabetes medications
- Patients unable to achieve their HbA1c goal despite focused efforts
- Patients with frequent or extreme glucose excursions (>200 mg/dL, within day or day-to-day)
- or All of the above?

Follow the link to see how you and your colleagues compare.

Read More »

SGLT2 Inhibitors: A New Class of Diabetes Medications

SGLT2-1HIW

What is a SGLT2 Inhibitor? Sodium-glucose co-transporter 2 (SGLT2) inhibitors, also called gliflozin drugs,  are a new class of diabetic medications indicated for the treatment of type 2 diabetes. They have also been found to show cardiac benefits in patients with diabetes, and are being studied for possible use in type 1 diabetes. They work by reducing the absorption of glucose via the kidneys so that excess glucose is excreted through urination.

Read More »